These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 123490)

  • 1. 1.3 Bis-(2 chloroethyl)-1-nitrosourea and streptozotocin chemotherapy.
    Lokich JJ; Chawla PL; Frei E
    Clin Pharmacol Ther; 1975 Mar; 17(3):374-8. PubMed ID: 123490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
    Panella TJ; Smith DC; Schold SC; Rogers MP; Winer EP; Fine RL; Crawford J; Herndon JE; Trump DL
    Cancer Res; 1992 May; 52(9):2456-9. PubMed ID: 1533174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B plus 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC no. 409962) in advanced cancer. Phase I and preliminary phase II results.
    Presant CA; Klahr C; Olander J; Gatewood D
    Cancer; 1976 Nov; 38(5):1917-21. PubMed ID: 991105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
    Macdonald JS; Hoth D; Schein PS
    Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide.
    Moertel CG; Douglas HO; Hanley J; Carbone PP
    Cancer; 1977 Aug; 40(2):605-8. PubMed ID: 142579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.
    Lohrmann HP; Lepp KA; Schreml W
    J Natl Cancer Inst; 1982 Apr; 68(4):541-7. PubMed ID: 6951071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.
    Nagarkatti M; Toney DM; Nagarkatti PS
    Cancer Res; 1989 Dec; 49(23):6587-92. PubMed ID: 2573418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin.
    Giuliani FC; Zirvi KA; Kaplan NO; Goldin A
    Int J Cancer; 1981 Jan; 27(1):5-13. PubMed ID: 7251230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea (FIVB) in colon cancer.
    Falkson G; Falkson HC
    Cancer Chemother Pharmacol; 1981; 6(1):31-4. PubMed ID: 7023714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer.
    Kovach JS; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    Cancer; 1974 Feb; 33(2):563-7. PubMed ID: 4812773
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of 1,3-bis(2-chloroethyl)-nitrosourea (BCNU; NSC-409962) with fluoxymesterone (NSC-12165) in the treatment of solid tumors.
    Reyes ES; Talley RW; O'Bryan RM; Gastesi RA
    Cancer Chemother Rep; 1973 Apr; 57(2):225-30. PubMed ID: 4582564
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastric cancer: current status of treatment.
    Carter SK; Comis RL
    J Natl Cancer Inst; 1977 Mar; 58(3):567-78. PubMed ID: 402478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of O6-alkylguanine alkyltransferase-directed DNA repair in metastatic colon cancers.
    Willson JK; Haaga JR; Trey JE; Stellato TA; Gordon NH; Gerson SL
    J Clin Oncol; 1995 Sep; 13(9):2301-8. PubMed ID: 7666087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
    Marathi UK; Dolan ME; Erickson LC
    Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations.
    Bodell WJ
    Anticancer Res; 2000; 20(5A):3099-103. PubMed ID: 11062728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.
    Koç ON; Reese JS; Davis BM; Liu L; Majczenko KJ; Gerson SL
    Hum Gene Ther; 1999 Apr; 10(6):1021-30. PubMed ID: 10223735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice.
    Bibby MC; Thompson MJ; Rafferty JA; Margison GP; McElhinney RS
    Br J Cancer; 1999 Mar; 79(9-10):1332-9. PubMed ID: 10188873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age.
    Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G
    Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.